Cuiqing Yang

Title: Innovations of Cuiqing Yang in Antibody Development

Introduction

Cuiqing Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating various types of cancer.

Latest Patents

Cuiqing Yang holds a patent for an "Anti-CD79B antibody, antigen-binding fragment thereof, and pharmaceutical use thereof." This invention relates to an anti-CD79B antibody and its antigen-binding fragments, which have potential pharmaceutical applications. The patent emphasizes the development of a chimeric antibody and a humanized antibody that includes a CDR region of the anti-CD79B antibody. Furthermore, it discusses a pharmaceutical composition that incorporates the anti-CD79B antibody or its fragments, highlighting its use as an anti-cancer drug. Notably, this invention is particularly relevant for the treatment of lymphoma, including DLBCL.

Career Highlights

Cuiqing Yang is associated with Tuojie Biotech (Shanghai) Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to innovative cancer therapies.

Collaborations

Cuiqing Yang collaborates with Renhong Tang, enhancing the research and development capabilities within their organization. Their partnership aims to drive forward the development of effective therapeutic solutions.

Conclusion

Cuiqing Yang's innovative work in antibody development showcases his commitment to advancing cancer treatment. His patent on the anti-CD79B antibody represents a significant step forward in biotechnology, with the potential to improve patient outcomes in lymphoma treatment.